N/A

Markets. It is always a mixed blessing when you get a correction. It pains him to see all the red numbers on the screen, but there are some bargains emerging. Stocks are selling off in the absence of any hard reason, so obviously there are bargains. He saw an outflow of funds from equities. When you see this kind of volatility, buyers go on strike. This is when you should be looking the hardest. We are three weeks away from the third quarter earnings announcements and we have seen a lot of revisions downwards. He is not seeing a lot of earnings warnings. Now is when we should see them. He takes this to be a good sign. There will be pervasive weakness in energy and commodities. People are worrying about a spillover to the banks. He thinks there is nothing serious going on this quarter. He sees no sign of a recession in the US. He looks at alternatives. Long bonds return negative return after taxes, but high quality equities are paying 3-5% dividends. The dividends should be lower, meaning the stock prices should be higher.

BUY

He always wanted to own it and took advantage of the pullback. It is not trading at too high a multiple. This is the most attractive buy-in opportunity he has had.

BUY

He likes it and is looking at it right now. He likes the dividend and how it increases year after year. He likes the healthcare sector. He prefers disposable products more than pharma. It has not made anyone any money this year so it is now one to take a look at. He expects 7-9% return compounded over the next 10 years.

DON'T BUY

It may only be a matter of time until the dividend goes to zero. People were chasing yield at their peril. As oil prices came down, so had the dividend to. It is only a matter of time before they cut it again.

BUY

He imagines they are shopping right now because there is money to finance an acquisition. This is an opportunity to get in. The insiders own a lot of stock so it would be a hard company to acquire.

BUY

He regrets not owning it. They have executed very well. He always felt it was expensive and that is why he does not own it. If Canada is in a zero growth mode, he assumes people are shopping for bargains. If they were to miss earnings, you always have to look at why. It could create a better opportunity to buy in.

DON'T BUY

They are bottom shopping and for a good reason. He is concerned about what he is reading about infrastructure in gas and in particular LNG. He was very bullish on LNG going back 10 years. Now nothing has happened on the west coast, however.

RISKY

During ‘08/’09 it went way down below $4 because people were worried about their ability to service the debt. Coal is a bit of a disaster right now. Zinc is at a 5 year low. If they had no debt it would be a great time to buy in, but that is not the case. No one knows what is going to happen to commodity prices.

N/A

Copper Producer. He would go to the States and get a long term producer. FCX-N, for example, would be better than a Canadian producer. It could be a long trough on the commodity price.

PAST TOP PICK

(Top Pick Oct 20/14, Up 18.26%) The whole VW business to the extent it has caused contagion is ridiculous. It is just a matter of a fine and it will be years from now. It is an opportunity here.

PAST TOP PICK

(Top Pick Oct 20/14, Down 12.39%) it is unjustified. Banks make money in all kinds of ways, not just spreads.

PAST TOP PICK

(Top Pick Oct 20/14, Down 16.72%) He likes it for the dividend and their increases. The pipelines act like they are oil producers, which they are not. Keystone is priced out of the stock.

DON'T BUY

A well run company. They are a price taker, however. He needs something to change the supply/demand equation in oil. We are now going to see vastly more oil coming out of Iran. Frackers in North Dakota are continuing to produce. The middle east thought by driving down prices they would put them out of business. Both sides of the equation are pretty scary.

DON'T BUY

He has always been slightly cautious of the patent protected pharma industry. Drugs are very expensive to create, then eventually they come off patent and also there is always the risk of litigation. He prefers TEVA-N, who changed a drug to be several times ago and were able to extend their patent.

DON'T BUY

It scares him because it is so unanalyzable. There are so many moving parts and so much debt. He won’t buy what he can’t understand.